カテゴリ： IMARC, 世界, 医療/バイオ

生物製剤のグローバル市場：産業動向、シェア、規模、成長、機会・予測（2023～2028）

■ 英語タイトル：Biologics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

調査会社IMARC社が発行したリサーチレポート（データ管理コード：IMARC23AP134）■ 発行会社/調査会社：IMARC
■ 商品コード：IMARC23AP134
■ 発行日：2023年3月2日
■ 調査対象地域：グローバル
■ 産業分野：医療
■ ページ数：146
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール
■ 販売価格オプション（消費税別）
Single UserUSD2,999 ⇒換算￥455,848見積依頼/購入/質問フォーム
Five UserUSD3,999 ⇒換算￥607,848見積依頼/購入/質問フォーム
EnterprisewideUSD4,999 ⇒換算￥759,848見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※IMARC社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[生物製剤のグローバル市場：産業動向、シェア、規模、成長、機会・予測（2023～2028）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

IMARC社の本調査資料では、2022年に3,210億ドルを記録した世界の生物製剤市場規模が、2028年までに5,355億ドルに達し、予測期間中に年平均8.1%で成長すると展望しています。本書は、生物製剤の世界市場を調査対象とし、市場実態を明らかにするとともに、今後の動向を予想しています。序論、範囲・調査手法、エグゼクティブサマリー、イントロダクション、ソース別（微生物、哺乳類、その他）分析、製品別（モノクローナル抗体、ワクチン、リコンビナントタンパク質、アンチセンス・RNAi・分子療法、その他）分析、疾患別（腫瘍、免疫疾患、心血管系疾患、血液疾患、その他）分析、製造別（アウトソーシング、インハウス）分析、地域別（北米、アジア太平洋、ヨーロッパ、中南米、中東・アフリカ）分析、SWOT分析、バリューチェーン分析、ポーターズファイブフォース分析、価格分析、競争状況などを整理しています。主要参入企業として、AbbVie Inc.、Amgen Inc.、AstraZeneca plc、F. Hoffmann-La Roche Ltd、GlaxoSmithKline plc、Johnson & Johnson、Merck KGaA、Novartis AG、Pfizer Inc. and Sanofi.などの情報が含まれています。
・序論
・範囲・調査手法
・エグゼクティブサマリー
・イントロダクション
・世界の生物製剤市場規模：ソース別
- 微生物由来製剤の市場規模
- 哺乳類由来製剤の市場規模
- その他の市場規模
・世界の生物製剤市場規模：製品別
- モノクローナル抗体の市場規模
- ワクチンの市場規模
- リコンビナントタンパク質の市場規模
- アンチセンス・RNAi・分子療法の市場規模
- その他の市場規模
・世界の生物製剤市場規模：疾患別
- 腫瘍における市場規模
- 免疫疾患における市場規模
- 心血管系疾患における市場規模
- 血液疾患における市場規模
- その他における市場規模
・世界の生物製剤市場規模：製造別
- アウトソーシングにおける市場規模
- インハウスにおける市場規模
・世界の生物製剤市場規模：地域別
- 北米の生物製剤市場規模
- アジア太平洋の生物製剤市場規模
- ヨーロッパの生物製剤市場規模
- 中南米の生物製剤市場規模
- 中東・アフリカの生物製剤市場規模
・SWOT分析
・バリューチェーン分析
・ポーターズファイブフォース分析
・価格分析
・競争状況

The global biologics market size reached US$ 321.0 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 535.5 Billion by 2028, exhibiting a growth rate (CAGR) of 8.1% during 2023-2028.

Biologics, also known as biological drugs, are disease-modifying antirheumatic drugs (DMARDs) made from living organisms or consist of components of living organisms. They include a wide variety of products, such as vaccines, blood, blood components, cells, genes, tissues, allergens, and recombinant proteins, derived from humans, animals, birds, insects, plants, and microorganisms. These products control the production of vital proteins, modify human hormones and cells, while producing substances to activate and suppress the immune system. They also change the manner of operation of natural biologic intracellular and cellular actions. In recent years, biologics have gained immense traction as they are essentially utilized to treat various diseases and conditions, including Crohn’s disease, ulcerative colitis, rheumatoid arthritis and other autoimmune diseases.

Biologics Market Trends:
The global biologics market is primarily driven by the rising incidences and diagnosis of chronic diseases that have necessitated the availability of advanced diagnostics and treatment drugs. Biologics are genetically engineered to target a specific part of the immune system that fuels inflammation. Governments of different countries are also taking initiatives to promote the healthcare sector and ensure the availability of biologics with the onset of coronavirus disease (COVID-19). Furthermore, scientists and researchers are extensively investigating species and expression systems to enhance the productivity of biological products. Moreover, various pharmaceutical companies are undertaking research and development (R&D) activities to improve the efficacy of oral products for rheumatoid arthritis and Crohn’s diseases.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global biologics market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on source, product, disease and manufacturing.

Breakup by Source:
Microbial
Mammalian
Others

Breakup by Product:
Monoclonal Antibodies
Vaccines
Recombinant Proteins
Antisense, RNAi and Molecular Therapy
Others

Breakup by Disease:
Oncology
Immunological Disorders
Cardiovascular Disorders
Hematological Disorders
Others

Breakup by Manufacturing:
Outsourced
In-House

Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being AbbVie Inc., Amgen Inc., AstraZeneca plc, F. Hoffmann-La Roche Ltd, GlaxoSmithKline plc, Johnson & Johnson, Merck KGaA, Novartis AG, Pfizer Inc. and Sanofi.

Key Questions Answered in This Report
1. What was the size of the global biologics market in 2022?
2. What is the expected growth rate of the global biologics market during 2023-2028?
3. What are the key factors driving the global biologics market?
4. What has been the impact of COVID-19 on the global biologics market?
5. What is the breakup of the global biologics market based on the source?
6. What is the breakup of the global biologics market based on the product?
7. What is the breakup of the global biologics market based on the disease?
8. What is the breakup of the global biologics market based on the manufacturing?
9. What are the key regions in the global biologics market?
10. Who are the key players/companies in the global biologics market?

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Biologics Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Source
6.1 Microbial
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Mammalian
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Others
6.3.1 Market Trends
6.3.2 Market Forecast
7 Market Breakup by Product
7.1 Monoclonal Antibodies
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Vaccines
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Recombinant Proteins
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Antisense, RNAi and Molecular Therapy
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast
8 Market Breakup by Disease
8.1 Oncology
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Immunological Disorders
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Cardiovascular Disorders
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Hematological Disorders
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Others
8.5.1 Market Trends
8.5.2 Market Forecast
9 Market Breakup by Manufacturing
9.1 Outsourced
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 In-House
9.2.1 Market Trends
9.2.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 AbbVie Inc.
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 Amgen Inc.
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 Financials
15.3.2.4 SWOT Analysis
15.3.3 AstraZeneca plc
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.3.4 SWOT Analysis
15.3.4 F. Hoffmann-La Roche Ltd
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 SWOT Analysis
15.3.5 GlaxoSmithKline plc
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 Financials
15.3.5.4 SWOT Analysis
15.3.6 Johnson & Johnson
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 Financials
15.3.6.4 SWOT Analysis
15.3.7 Merck KGaA
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.7.4 SWOT Analysis
15.3.8 Novartis AG
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.8.4 SWOT Analysis
15.3.9 Pfizer Inc.
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis
15.3.10 Sanofi
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 Financials
15.3.10.4 SWOT Analysis

Figure 1: Global: Biologics Market: Major Drivers and Challenges
Figure 2: Global: Biologics Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Biologics Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Biologics Market: Breakup by Source (in %), 2022
Figure 5: Global: Biologics Market: Breakup by Product (in %), 2022
Figure 6: Global: Biologics Market: Breakup by Disease (in %), 2022
Figure 7: Global: Biologics Market: Breakup by Manufacturing (in %), 2022
Figure 8: Global: Biologics Market: Breakup by Region (in %), 2022
Figure 9: Global: Biologics (Microbial) Market: Sales Value (in Million US$), 2017 & 2022
Figure 10: Global: Biologics (Microbial) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 11: Global: Biologics (Mammalian) Market: Sales Value (in Million US$), 2017 & 2022
Figure 12: Global: Biologics (Mammalian) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 13: Global: Biologics (Other Sources) Market: Sales Value (in Million US$), 2017 & 2022
Figure 14: Global: Biologics (Other Sources) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 15: Global: Biologics (Monoclonal Antibodies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 16: Global: Biologics (Monoclonal Antibodies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 17: Global: Biologics (Vaccines) Market: Sales Value (in Million US$), 2017 & 2022
Figure 18: Global: Biologics (Vaccines) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 19: Global: Biologics (Recombinant Proteins) Market: Sales Value (in Million US$), 2017 & 2022
Figure 20: Global: Biologics (Recombinant Proteins) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 21: Global: Biologics (Antisense, RNAi and Molecular Therapy) Market: Sales Value (in Million US$), 2017 & 2022
Figure 22: Global: Biologics (Antisense, RNAi and Molecular Therapy) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 23: Global: Biologics (Other Products) Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: Global: Biologics (Other Products) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 25: Global: Biologics (Oncology) Market: Sales Value (in Million US$), 2017 & 2022
Figure 26: Global: Biologics (Oncology) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 27: Global: Biologics (Immunological Disorders) Market: Sales Value (in Million US$), 2017 & 2022
Figure 28: Global: Biologics (Immunological Disorders) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 29: Global: Biologics (Cardiovascular Disorders) Market: Sales Value (in Million US$), 2017 & 2022
Figure 30: Global: Biologics (Cardiovascular Disorders) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 31: Global: Biologics (Hematological Disorders) Market: Sales Value (in Million US$), 2017 & 2022
Figure 32: Global: Biologics (Hematological Disorders) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 33: Global: Biologics (Other Diseases) Market: Sales Value (in Million US$), 2017 & 2022
Figure 34: Global: Biologics (Other Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 35: Global: Biologics (Outsourced) Market: Sales Value (in Million US$), 2017 & 2022
Figure 36: Global: Biologics (Outsourced) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 37: Global: Biologics (In-House) Market: Sales Value (in Million US$), 2017 & 2022
Figure 38: Global: Biologics (In-House) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 39: North America: Biologics Market: Sales Value (in Million US$), 2017 & 2022
Figure 40: North America: Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 41: United States: Biologics Market: Sales Value (in Million US$), 2017 & 2022
Figure 42: United States: Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 43: Canada: Biologics Market: Sales Value (in Million US$), 2017 & 2022
Figure 44: Canada: Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 45: Asia-Pacific: Biologics Market: Sales Value (in Million US$), 2017 & 2022
Figure 46: Asia-Pacific: Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 47: China: Biologics Market: Sales Value (in Million US$), 2017 & 2022
Figure 48: China: Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 49: Japan: Biologics Market: Sales Value (in Million US$), 2017 & 2022
Figure 50: Japan: Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 51: India: Biologics Market: Sales Value (in Million US$), 2017 & 2022
Figure 52: India: Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 53: South Korea: Biologics Market: Sales Value (in Million US$), 2017 & 2022
Figure 54: South Korea: Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 55: Australia: Biologics Market: Sales Value (in Million US$), 2017 & 2022
Figure 56: Australia: Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 57: Indonesia: Biologics Market: Sales Value (in Million US$), 2017 & 2022
Figure 58: Indonesia: Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 59: Others: Biologics Market: Sales Value (in Million US$), 2017 & 2022
Figure 60: Others: Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 61: Europe: Biologics Market: Sales Value (in Million US$), 2017 & 2022
Figure 62: Europe: Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 63: Germany: Biologics Market: Sales Value (in Million US$), 2017 & 2022
Figure 64: Germany: Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 65: France: Biologics Market: Sales Value (in Million US$), 2017 & 2022
Figure 66: France: Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 67: United Kingdom: Biologics Market: Sales Value (in Million US$), 2017 & 2022
Figure 68: United Kingdom: Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 69: Italy: Biologics Market: Sales Value (in Million US$), 2017 & 2022
Figure 70: Italy: Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 71: Spain: Biologics Market: Sales Value (in Million US$), 2017 & 2022
Figure 72: Spain: Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 73: Russia: Biologics Market: Sales Value (in Million US$), 2017 & 2022
Figure 74: Russia: Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 75: Others: Biologics Market: Sales Value (in Million US$), 2017 & 2022
Figure 76: Others: Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 77: Latin America: Biologics Market: Sales Value (in Million US$), 2017 & 2022
Figure 78: Latin America: Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 79: Brazil: Biologics Market: Sales Value (in Million US$), 2017 & 2022
Figure 80: Brazil: Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 81: Mexico: Biologics Market: Sales Value (in Million US$), 2017 & 2022
Figure 82: Mexico: Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 83: Others: Biologics Market: Sales Value (in Million US$), 2017 & 2022
Figure 84: Others: Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 85: Middle East and Africa: Biologics Market: Sales Value (in Million US$), 2017 & 2022
Figure 86: Middle East and Africa: Biologics Market: Breakup by Country (in %), 2022
Figure 87: Middle East and Africa: Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 88: Global: Biologics Industry: SWOT Analysis
Figure 89: Global: Biologics Industry: Value Chain Analysis
Figure 90: Global: Biologics Industry: Porter's Five Forces Analysis

Table 1: Global: Biologics Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Biologics Market Forecast: Breakup by Source (in Million US$), 2023-2028
Table 3: Global: Biologics Market Forecast: Breakup by Product (in Million US$), 2023-2028
Table 4: Global: Biologics Market Forecast: Breakup by Disease (in Million US$), 2023-2028
Table 5: Global: Biologics Market Forecast: Breakup by Manufacturing (in Million US$), 2023-2028
Table 6: Global: Biologics Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 7: Global: Biologics Market: Competitive Structure
Table 8: Global: Biologics Market: Key Players

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 臨床栄養のグローバル市場：産業動向、シェア、規模、成長、機会・予測（2023～2028）
  • バイオマーカーのグローバル市場：産業動向、シェア、規模、成長、機会・予測（2023～2028）
  • 中枢神経系（CNS）治療のグローバル市場：産業動向、シェア、規模、成長、機会・予測（2023～2028）
  • アフェレシスのグローバル市場：産業動向、シェア、規模、成長、機会・予測（2023～2028）
  • 細胞療法のグローバル市場：産業動向、シェア、規模、成長、機会・予測（2023～2028）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(IMARC23AP134 )"生物製剤のグローバル市場：産業動向、シェア、規模、成長、機会・予測（2023～2028）" (英文：Biologics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028)はIMARC社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。